2020-02-26| Asia-Pacific

Company Presentations at BIO Asia-Taiwan 2020 Now Accepting Applications

by GeneOnline
Share To

With the roaring success in 2019, the BIO Asia-Taiwan International Conference and Exhibition, co-organized by Biotechnology Innovation Organization (BIO) and Taiwan Bio Industry Organization (Taiwan BIO), is once again welcoming biomedical disciplines and industries to participate in one of the largest gatherings in the Asia Pacific region in July 2020 at the newly constructed Taipei Nangang Exhibition Center, Hall 2.

The five-day BIO Asia-Taiwan International Conference and Exhibition offers a packed schedule of events, including exhibitions, company presentations, BIO One-on-One Partnering™ meetings, seminars, workshops, and social gatherings from July 22nd to July 26th, 2020 in Taipei, Taiwan.

With 1700 booths from 650 exhibitors expected, not only the exhibitors will have the opportunity to showcase their companies, innovations, products, or services during the four-day exhibition to investors and professionals, all attendees will also have the chance to engage with global companies and stay ahead of the latest trends in biopharmaceutical, precision medicines, smart medical, and medical devices, etc..

Whether you are a venture capital firm, a start-up entrepreneur, or a well-established company, the Company Presentations session will provide the advantages of making a more direct connection and increase visibility with a richly-targeted audience of global investors, deal-making partners, and future customers, participating company can also maximize meeting efficiency by levering the BIO One-on-One Partnering™ system, an easy-to-use online meeting scheduling system to search for and identify potential partners, collaborators, investors and in- and out-licensing opportunities. With over 2,000 face-to-face meetings made via the system during BIO Asia–Taiwan 2019, we expect over 3,500 meetings to be successfully scheduled during the 2020 event.

Company Presentations is now accepting applications till March 31st, learn more at 2020 Company Presentations.


© All rights reserved. Collaborate with us:
Related Post
Biotech Start-ups May Face a Foreboding Prospect Following Silicon Valley Bank (SVB)’s Unsuspected Collapse
BIO Asia-Taiwan 2022: Looking for the Exit; Startup Considerations and Strategies
BIO Asia-Taiwan 2022: Top iPS Cell Technologies at Affordable Prices – Keynote by Nobel Laureate Shinya Yamanaka
Kite’s Yescarta Yields a Success in a Phase 3 Trial for Treating Large B-Cell Lymphoma
Transcenta Announces First Patient Dosed in the U.S. Study of Its First-In-Class Gremlin1 Targeting Antibody TST003 for the Treatment of Solid Tumors
Biogen’s Tofersen May Show Clinical Benefit in ALS Patients with Rare SOD1 Mutations
Comparing ESG Regulations in the U.S., the U.K., and the EU
See-Mode Technologies Secures Regulatory Approvals for its AI-powered Software that Automatically Analyses and Reports Breast & Thyroid Ultrasound Scans in Australia and New Zealand
OncoC4 Bags $200 Million In CTLA-4 Antibody Pact With BioNTech
HHS Issues Initial Guidance on Negotiation Program as Government’s Latest Move to Reduce Drug Prices
Scroll to Top